These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24908282)

  • 1. Cyclosporin A-induced posterior reversible encephalopathy syndrome in an adolescent with steroid-resistant nephrotic syndrome.
    Hacihamdioğlu DÖ; Gökhan A; Cihan M; Mul K; Ferhan K; Süleymanoğlu S
    Int Urol Nephrol; 2014 Oct; 46(10):2055-6. PubMed ID: 24908282
    [No Abstract]   [Full Text] [Related]  

  • 2. Posterior reversible encephalopathy syndrome.
    Akl KF; Samara OA
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):957-8. PubMed ID: 20814143
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporin-A induced posterior reversible encephalopathy syndrome.
    Saeed B; Abou-Zor N; Amer Z; Kanani I; Hilal M
    Saudi J Kidney Dis Transpl; 2008 May; 19(3):439-42. PubMed ID: 18445907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome.
    Ishikura K; Ikeda M; Hamasaki Y; Hataya H; Nishimura G; Hiramoto R; Honda M
    Nephrol Dial Transplant; 2008 Aug; 23(8):2531-6. PubMed ID: 18258739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior reversible encephalopathy syndrome (PRES) induced by cyclosporine use in a patient with collapsing focal glomeruloesclerosis.
    de Oliveira RA; Fechine LM; Neto FC; Nicodemus JM; Silva GB; Silva LS
    Int Urol Nephrol; 2008; 40(4):1095-8. PubMed ID: 18661248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior Reversible Encephalopathy Syndrome in a Normotensive Child after Allogeneic Hematopoietic Stem Cell Transplantation.
    Kartal Ö; Gürsel O; Ünay B; Arda KN; Atas E
    P R Health Sci J; 2019 Dec; 38(4):272-274. PubMed ID: 31935316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early onset of posterior reversible encephalopathy syndrome (PRES) during Cyclosporine-A infusion.
    Torelli GF; Natalino F; Barberi W; Iori AP; Andreoli C; Valle V; Mercanti C; Perrone S; Gualdi G; Foà R
    Leuk Res; 2011 Oct; 35(10):1423-4. PubMed ID: 21397327
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine-related brainstem atypical posterior reversible leukoencephalopathy syndrome following hematopoietic stem cell transplant.
    Yafour N; Krim A; Bouhass R; Bekadja MA
    Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):36-8. PubMed ID: 25979822
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppressive Drugs, an Emerging Cause of Posterior Reversible Encephalopathy Syndrome: Case Series.
    Harirchian MH; Ghaffarpour M; Tabaeizadeh M; Siroos B
    J Stroke Cerebrovasc Dis; 2015 Aug; 24(8):e191-5. PubMed ID: 26082344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin-related nephrotoxicity in children with nephrotic syndrome.
    Ganesan V; Milford DV; Taylor CM; Hulton SA; Parvaresh S; Ramani P
    Pediatr Nephrol; 2002 Mar; 17(3):225-6; author reply 227. PubMed ID: 11956868
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapies for steroid-resistant nephrotic syndrome.
    Hodson EM; Craig JC
    Pediatr Nephrol; 2008 Sep; 23(9):1391-4. PubMed ID: 18368428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Rituximab in Children With Steroid- and Cyclosporine-resistant and Steroid- and Cyclosporine-dependent Nephrotic Syndrome.
    Hoseini R; Sabzian K; Otukesh H; Zafaranloo N; Panahi P; Rahimzadeh N; Nakhaie S; Akhavan Sepehi M
    Iran J Kidney Dis; 2018 Jan; 12(1):27-32. PubMed ID: 29421774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior reversible encephalopathy syndrome in childhood: report of four cases and review of the literature.
    Endo A; Fuchigami T; Hasegawa M; Hashimoto K; Fujita Y; Inamo Y; Mugishima H
    Pediatr Emerg Care; 2012 Feb; 28(2):153-7. PubMed ID: 22307182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of corticoid-resistant nephrotic syndrome: a still unresolved problem].
    Damiani B; Giani M; Consalvo G; Carcano A; Ghio L; Edefonti A
    Pediatr Med Chir; 1995; 17(1):9-15. PubMed ID: 7739938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late fulminant posterior reversible encephalopathy syndrome after liver transplant.
    Heidenhain C; Puhl G; Neuhaus P
    Exp Clin Transplant; 2009 Sep; 7(3):180-3. PubMed ID: 19715529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive therapy for nephrotic syndrome and strategy for adverse side effects from that therapy].
    Takeda Y; Tomino Y
    Nihon Rinsho; 2004 Oct; 62(10):1875-9. PubMed ID: 15500133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posterior reversible encephalopathy syndrome in a child with steroid-resistant nephrotic syndrome: a case report and review of literature.
    Zhang Y; Zhou J; Chen Y
    Int J Clin Exp Pathol; 2014; 7(7):4433-7. PubMed ID: 25120830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible posterior encephalopathy syndrome in children with nephrotic syndrome.
    Zhou J; Zheng H; Zhong X; Wu D; Wang M; Tang X; Li Q
    Nephrology (Carlton); 2015 Nov; 20(11):849-54. PubMed ID: 26014660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine-Associated Pericardial Tamponade in a Child with Steroid-Resistant Nephrotic Syndrome.
    Rajalakshmi SL; Raman V; Ekambaram S; Subramaniyam G; Gowrishankar NC; Nammalwar BR
    Indian J Pediatr; 2021 Jun; 88(6):597. PubMed ID: 33825130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.